nanotechnolog
recent
develop
art
manipul
materi
especi
atom
molecular
scale
level
build
nanoscal
structur
chemic
devic
mukherje
del
grosso
et
al
nation
nanotechnolog
initi
astm
intern
defin
nanotechnolog
term
refer
technolog
manufactur
manipul
materi
dimens
nm
exploit
novel
properti
expand
design
character
synthesi
limit
toxic
applic
nanomateri
khajeh
et
al
kaur
et
al
nanostructur
defin
specifi
structur
object
antimicrobi
agent
hydrophil
natur
unabl
enter
microbi
cell
addit
intern
antimicrobi
molecul
rapidli
degrad
lysosom
activ
lead
reduc
antimicrobi
activ
drug
park
et
al
parida
et
al
therefor
new
technolog
expect
releas
antimicrobi
drug
within
microbi
cell
may
drug
deliveri
system
use
passiv
action
infect
cell
via
mononuclear
phagocyt
system
may
enhanc
therapeut
index
antimicrobi
along
reduct
side
effect
park
et
al
addit
system
administr
antimicrobi
affect
host
system
therefor
nanoparticl
nanomedicin
futur
antimicrobi
therapi
produc
celland
targetspecif
action
nanoscal
rang
without
alter
host
cell
function
basnet
skalkobasnet
regard
bacteri
infect
develop
resist
antibiot
major
problem
antimicrobi
therapi
basnet
skalkobasnet
resist
antibiot
occur
follow
three
reason
modif
activ
site
drugbind
protein
destruct
modif
antibiot
enzymat
mechan
organ
activ
efflux
mechan
antibiot
organ
borgeswalmsley
et
al
arenz
wilson
hope
nanoparticl
carri
antimicrobi
agent
nanoscal
level
releas
target
site
infecti
organ
therefor
nanoparticl
greater
potenti
elimin
microb
avoid
develop
resist
pelgrift
friedman
leid
et
al
howev
mutat
mycobacterium
resist
silver
nanoparticl
load
isoniazid
document
howev
resist
occur
silver
nanoparticl
wherea
cuso
znso
particl
produc
microbi
resist
larim
et
al
addit
antimicrobialload
nanoparticl
enter
host
cell
includ
brain
region
via
endocytosi
process
follow
releas
preload
drug
microb
martin
et
al
nanoparticul
system
show
enorm
potenti
target
drug
deliveri
especi
neuroinfect
condit
brain
leit
et
al
howev
implement
nanomedicin
neuroinfecti
diseas
antimicrobi
therapi
signific
challeng
gener
drug
deliveri
system
multifunct
action
ie
switch
switch
function
requir
multifunct
drug
deliveri
system
must
harmon
optim
fashion
gendelman
et
al
nanoparticleassist
antimicrobi
drug
deliveri
challeng
produc
improv
efficaci
avoid
resist
extrem
desir
treatment
neuroinfect
diseas
garg
et
al
howev
nanomedicin
special
properti
advantag
antimicrobi
drug
deliveri
drug
action
microbi
infect
nervou
system
jong
huang
dando
et
al
antimicrobi
nanoparticl
possess
six
major
properti
support
use
clinic
set
follow
surfac
properti
nanoparticl
chang
target
drug
deliveri
case
small
molecul
protein
peptid
nucleic
acid
load
nanoparticl
reject
immun
system
effect
reach
target
site
special
tissu
boraschi
et
al
nanocarri
support
solubl
stabil
drug
target
cell
minim
side
effect
host
cell
singh
nanotechnolog
allow
codeliveri
two
drug
form
combin
therapi
multipl
pathogen
hu
et
al
antimicrobi
nanoparticl
potenti
overcom
microbi
resist
common
bacteri
organ
garg
et
al
administr
antimicrobi
drugload
nanoparticl
enhanc
therapeut
index
extend
halflif
system
circul
lead
control
releas
microbi
drug
improv
overal
pharmacokinet
bisht
maitra
chen
et
al
administr
antimicrobi
drugload
nanoparticl
possibl
via
differ
rout
oral
nasal
parenter
intraocular
fonsecasanto
et
al
almeida
et
al
therefor
great
interest
develop
antimicrobi
nanoparticl
newer
method
drug
therapi
neuroinfecti
diseas
variou
nanostructur
design
develop
nanoparticl
nanomedicin
medic
system
wide
use
diagnosi
drug
deliveri
system
cancer
treatment
variou
nanomateri
like
au
ag
zno
cucuo
tio
al
ceo
use
nanomedicin
explor
antimicrobi
activ
ge
et
al
fu
et
al
nanoparticl
uniqu
physicochem
properti
eg
ultrasmal
size
less
nm
control
size
larg
surfac
areatomass
ratio
high
reactiv
solubl
targetspecif
action
properti
nanoparticl
allow
act
nanomedicin
size
natur
function
unit
live
organ
like
dna
nm
small
rna
ribosom
nm
microtubul
nm
nuclear
pore
nm
variou
protein
lipid
equal
less
nm
shang
et
al
matea
et
al
signific
innov
nanoparticl
overcom
limit
tradit
diagnost
therapeut
agent
furthermor
small
size
nanoparticl
provid
extrem
mobil
capac
interact
biolog
system
saptarshi
et
al
howev
research
studi
suggest
smaller
nanoparticl
expect
produc
toxic
higher
reactiv
variou
biolog
protein
peptid
mu
et
al
zaman
et
al
properti
nanoparticl
rais
safeti
issu
nanomedicin
fact
initi
find
reveal
nanoparticl
easili
penetr
propag
live
organ
compar
studi
show
potenti
benefit
diagnosi
cure
diseas
without
risk
immun
system
lung
digest
mucosa
skin
primari
goal
nanoparticl
medicin
design
targetand
sitespecif
deliveri
system
accur
therapeut
dose
biodegrad
polym
use
deliveri
drug
specif
locat
owe
potenti
inher
capac
marin
et
al
phenomenon
attract
great
interest
creat
revolut
usag
nanomedicin
field
pharmaceut
scienc
variou
structur
nanoparticl
found
applic
biomed
research
nanoparticl
inorgan
metal
oxid
polym
solid
lipid
ferritin
liposom
nanocryst
nanotub
nanofib
nanopor
nanosheet
quantum
dot
dendrim
mu
et
al
tauran
et
al
nanoparticl
show
promis
result
drug
deliveri
neuroprotect
system
molecular
mechan
upadhyay
khanbabai
jahanshahi
structur
variou
nanoparticl
illustr
fig
inorgan
nanoparticl
especi
gold
nanoparticl
affin
drug
coval
noncoval
bond
properti
enhanc
therapeut
efficaci
combin
action
gold
nanoparticl
laser
irradi
use
control
releas
drug
mieszawska
et
al
gold
nanoshelleantibodi
complex
known
produc
amelior
effect
cancer
diseas
due
select
transport
drug
cancer
cell
nuclei
conjug
arginineeglycineeaspart
acid
peptid
polyethylen
glycol
austin
et
al
contrast
produc
hyperthermia
use
noninvas
radio
frequenc
tumor
cell
gannon
et
al
raoof
curley
chatterje
et
al
silverco
nanoparticl
one
major
nanoparticl
antimicrobi
action
variou
nanos
particl
consid
novel
antibacteri
agent
high
surfac
area
reactiv
antimicrobi
activ
nanostructur
nanoparticl
convent
antimicrobi
agent
enhanc
compar
regular
antimicrobi
agent
beyth
et
al
addit
also
shown
produc
potent
antimicrobi
action
inhibit
microbi
growth
reproduct
properti
higher
silverdecor
polym
micel
polymer
vesicl
antimicrobi
polym
micel
vesicl
antimicrobi
peptidebas
vesicl
suchomel
et
al
histor
variou
organ
compound
hyaluron
acid
poli
gglutam
acid
polyhydroxyalkano
report
produc
widespectrum
antimicrobi
activ
natur
nanoparticl
shown
produc
antimicrobi
activ
compound
metal
deposit
eg
au
ag
cd
zn
fe
viruslik
particl
nanoscal
protein
strabl
et
al
arakha
et
al
silver
nanoparticl
identifi
broadspectrum
bactericid
virucid
nanomateri
also
use
cosmet
food
packag
materi
disinfect
clean
agent
etc
yah
simat
nickel
nanoparticl
use
purif
recombin
protein
nanomagnetiz
matrix
prepar
nejadmoghaddam
et
al
silicon
oxid
nanoparticl
use
earli
detect
cytotox
also
prepar
mucoadhes
nanosystem
vagin
microbicid
agent
optic
molecular
imag
materi
atherosclerosi
kompella
et
al
frees
et
al
najafzadeh
et
al
mesopor
silica
materi
use
detect
neisseria
meningitidi
transform
process
hollanda
et
al
current
research
evalu
antimicrobi
activ
polymer
nanostructur
biomedicin
armentano
et
al
iron
oxid
nanoparticl
inorgan
nanoparticl
classifi
base
size
iron
oxid
ie
standard
size
superparamagnet
iron
oxid
nm
ultrasmal
size
superparamagnet
iron
oxid
nm
subset
size
monocrystallin
iron
oxid
nm
variou
uniqu
properti
like
figur
structur
illustr
variou
nanoparticl
use
biomed
research
potenti
engag
drug
deliveri
diagnosi
treatment
drug
discoveri
process
current
document
produc
antimicrobi
neuroprotect
activ
therefor
futur
may
use
treat
neuroinfecti
disord
biocompat
intrins
abil
enhanc
magnet
reson
imag
mri
contrast
capac
surfac
modif
lead
enhanc
tumor
imag
activ
wang
et
al
standards
nanoparticl
compos
ferric
fe
ferrou
fe
iron
wahajuddin
arora
trap
reticuloendotheli
system
endocytosi
phagocytosi
explor
cytotox
profil
due
dissolv
capac
iron
oxid
acid
condit
liu
et
al
addit
fe
ion
store
adult
human
accumul
g
iron
therefor
solubl
iron
oxid
nanoparticl
neglig
avoid
metal
toxic
well
et
al
mri
cellular
system
iron
oxid
nanoparticl
coat
contrast
agent
sugar
eg
dextran
synthet
polym
eg
silicon
ciobanu
et
al
addit
also
report
produc
limit
toxic
compar
nanoparticl
rare
earth
materi
eg
lanthanid
silica
materi
also
use
prepar
nanoparticl
lanthanid
excel
build
block
multimod
imag
probe
luminesc
magnet
properti
heffern
et
al
gadolinium
gd
seven
unpair
electron
show
high
paramagnet
relax
therefor
also
use
imag
system
mri
shen
et
al
dope
lanthanid
eg
nayf
nanoparticl
also
use
yb
er
particl
liu
et
al
wang
et
al
great
interest
silica
nanoparticl
cancer
cell
imag
system
favor
properti
exampl
inert
optic
transpar
easi
modifi
structur
size
hydrophil
surfac
nanoparticl
silanol
esieoh
deproton
silanol
esieo
group
prepar
neutral
ph
make
silica
nanoparticl
dispers
water
lee
et
al
yang
et
al
enhanc
specif
bind
properti
silica
nanoparticl
target
site
avoid
aggreg
silica
nanoparticl
vivo
addit
silica
nanoparticl
quit
photost
fluoresc
dye
reduc
photochem
oxid
reactiv
oxygen
speci
vatansev
et
al
zhao
et
al
silica
materi
eg
mesopor
one
great
structur
control
function
magnet
luminesc
properti
due
larg
surfac
area
high
pore
volum
nontox
good
biocompat
proven
effect
drug
deliveri
system
bharti
et
al
moreov
mesopor
silica
nanoparticl
also
use
radionuclid
imag
process
label
radioisotop
xing
et
al
nanoparticl
structur
stabl
inorgan
system
porou
characterist
biodegrad
polym
wide
use
control
drug
deliveri
system
drugload
process
polymer
nanoparticl
entrap
encapsul
dissolut
dispers
particl
use
load
wide
varieti
hydrophob
hydrophil
drug
nitta
numata
zhao
et
al
formul
wide
use
drug
deliveri
tissu
engin
variou
biomed
applic
furthermor
surfac
polymer
nanoparticl
contain
variou
function
group
modifi
target
ligand
elsabahi
wooley
clinic
conjug
polymeredrug
import
role
drug
efficaci
reduct
dose
frequenc
convent
medicin
eliasof
et
al
particl
provid
greater
efficaci
antiasthmat
lu
et
al
antituberculosi
smith
pulmonari
hypertens
agyar
kandimalla
anticanc
drug
woo
et
al
contrast
report
biodegrad
toxic
polymer
nanoparticl
pulmonari
formul
marin
et
al
research
found
typic
ceram
nanoparticl
silica
alumina
also
potenti
drug
deliveri
properti
fine
et
al
addit
newer
biodegrad
synthet
polym
natur
modifi
polym
chitosan
albumin
also
involv
drug
deliveri
system
lohcharoenk
et
al
wang
et
al
furthermor
cytolyt
peptid
nanoparticl
nanobe
polymer
nanoparticl
encapsul
curcumin
use
cancer
treatment
human
ray
et
al
prepar
solidlipid
nanoparticl
lipidbas
submicromet
colloid
carrier
formul
wide
use
solidlipid
nanoparticl
glyce
behen
glycerol
palmitostear
lecithin
triglycerid
tristearin
glycerid
santo
et
al
case
larg
amount
surfact
need
stabil
formul
particl
use
prepar
protein
antigen
therapeut
purpos
sahdev
et
al
taki
smooker
formul
produc
good
anticanc
antivir
potenc
torrecilla
et
al
yu
et
al
addit
entrap
drug
solidlipid
nanoparticl
potenti
penetr
properti
time
tradit
deliveri
bloodebrain
barrier
treat
variou
central
nervou
system
disord
yener
liu
et
al
formul
indomethacin
ketoprofen
isoniazid
pyrazinamid
primaquin
solidlipid
nanoparticl
report
produc
benefici
effect
pulmonari
hematolog
gastrointestin
system
mansour
et
al
omwoyo
et
al
major
limit
prepar
load
effici
owe
format
lipid
crystal
matrix
chang
physic
state
lipid
valetti
et
al
ferritin
function
protein
live
organ
made
subunit
spontan
assembl
nanoparticl
show
cagelik
nanostructur
intern
diamet
extern
diamet
zhen
et
al
particl
allow
load
lead
compound
side
ie
insid
outsid
interfac
ferritin
nanoparticl
outer
surfac
ferritin
particl
modifi
chemic
genet
materi
caviti
ferritin
particl
abl
carri
wide
rang
metal
high
affin
theil
ferritin
nanoparticl
appli
carri
biovector
surfac
reach
target
c
melanoma
cancer
cell
xing
et
al
zhen
et
al
addit
gadoliniumload
ferritin
nanoparticl
enter
specif
tumor
endotheli
cell
kitagawa
et
al
stabl
ph
therefor
possess
rigid
physiolog
condit
easili
broken
acid
environ
lin
et
al
henc
use
targetspecif
action
diagnosi
treatment
tumor
cancer
cell
liposom
spheric
lipid
vesicl
bilay
membran
structur
introduc
drug
deliveri
year
liposom
nanoparticl
frequent
use
deliveri
antimicrobi
drug
kraft
et
al
monteiro
et
al
drugload
liposom
prepar
accord
size
rang
macrophag
liposom
digest
within
macrophag
phagosom
phagocytosi
process
releas
drug
content
schwenden
whittenton
et
al
addit
liposom
membran
also
incorpor
opsonin
activ
endocytosi
cell
type
major
distinguish
featur
liposom
lipid
bilay
structur
mimic
cell
membran
infecti
microb
readili
fuse
wang
et
al
oh
park
owe
properti
play
great
role
deliveri
antimicrobi
drug
directli
insid
microb
nanotub
selfassembl
sheet
atom
organ
tube
base
structur
classifi
two
major
categori
singlewal
cylindr
carbon
nanotub
multiwal
carbon
nanotub
multipl
cylind
nest
within
cylind
eatemadi
et
al
particl
uniqu
properti
electron
thermal
structur
characterist
produc
good
drug
deliveri
action
cancer
cell
significantli
reduc
cancer
cell
progress
addit
also
play
great
role
diagnosi
diseas
due
potenti
biosens
properti
use
treatment
cancer
diseas
low
dose
convent
drug
possess
targetspecif
action
cancer
cell
morri
tian
et
al
howev
toler
nanoparticl
remain
unidentifi
human
nanocryst
cluster
arrang
molecul
wrap
drug
molecul
thin
coat
surfact
materi
wide
use
chemic
engin
biolog
imag
system
compar
drug
deliveri
system
bian
et
al
prepar
use
hydrophob
compound
coat
thin
layer
hydrophil
compound
biolog
effect
nanocryst
depend
chemic
natur
hydrophil
coat
molecul
hydrophil
layer
also
act
aid
biolog
distribut
bioavail
crystallin
drug
materi
factor
respons
drug
drug
deliveri
lv
et
al
fay
et
al
nanosuspens
formul
use
via
oral
rout
overcom
difficulti
swallow
tablet
pediatr
geriatr
patient
nanofib
prepar
electrospin
method
wide
use
drug
deliveri
process
nanofib
arrang
fibrou
scaffold
abl
entrap
drug
larg
load
capac
high
encapsul
effici
due
low
weight
inher
larg
surfacetovolum
ratio
xu
et
al
zhang
et
al
nanofib
promis
carrier
molecul
deliveri
anticanc
drug
use
nanoparticl
postop
local
chemotherapi
use
surgic
implant
scaffold
tseng
et
al
tseng
et
al
nanoparticl
abl
protect
encapsul
drug
enzymat
hydrolyt
degrad
griffin
et
al
wade
et
al
evidenc
insulinload
nanoparticl
preserv
insulin
activ
produc
lower
blood
glucos
level
day
diabet
rat
nishimura
et
al
nanopor
member
nanoparticl
nanoscalelevel
channel
hole
freestand
membran
solidst
nanopor
silicon
sio
si
n
act
biolog
sensor
biolog
transmembran
protein
haqu
et
al
majd
et
al
ahemolysin
ahl
channel
one
common
nanoparticl
use
detect
singlestrand
nucleic
acid
modifi
ahl
nanopor
use
distinguish
individu
dna
mononucleotid
wanunu
reveal
nanopor
serv
potent
regul
dna
direct
sequenc
action
singl
molecul
dna
haqu
et
al
reliabl
lowcost
nanoparticl
dna
sequenc
process
genom
research
similar
properti
also
expect
regul
genet
inform
cancer
cell
wang
et
al
addit
polydimethylsiloxan
pdm
polym
use
produc
microfluid
channel
microscal
devic
valencia
et
al
briefli
nanoscal
devic
prepar
seal
pdm
polym
consist
two
reservoir
connect
pore
glass
materi
fill
ionic
solut
potenti
differ
across
pore
measur
constant
appli
current
fourpoint
techniqu
jain
et
al
liu
et
al
work
principl
nanopor
devic
flow
dna
molecul
pass
pore
creat
downward
spike
wave
current
record
profil
downward
peak
mimic
movement
singl
dna
molecul
nanopor
devic
nanopor
devic
help
detect
virus
viral
protein
crick
et
al
dorfman
et
al
furthermor
attach
biolog
membran
coval
bond
act
probe
molecul
detect
specif
target
site
nanopor
support
detect
antigeneantibodi
bind
reaction
schibel
ervin
antibodi
specif
bound
colloid
surfac
nanopor
rais
diamet
nanoparticl
limit
aris
materi
owe
signific
current
blockad
higher
resist
current
flow
due
larger
diamet
colloid
particl
belkin
et
al
devic
use
detect
presenc
streptococcu
group
sensit
detect
four
time
faster
standard
latex
agglutin
assay
major
advantag
nanopor
costeffect
simplic
speed
versatil
nanopor
assay
squir
et
al
therefor
particl
use
prepar
nanomed
devic
diagnosi
treatment
neurolog
disord
nanosheet
anoth
nanoparticl
arrang
singleor
multiplelay
twodimension
array
atom
molecul
graphen
one
nanosheet
materi
arrang
twodimension
honeycomb
crystal
structur
flat
monolay
carbon
atom
high
thermal
conduct
wm
k
high
specif
surfac
area
high
electron
mobil
cm
v
biocompat
thermal
stabil
therefor
use
electrochem
immunosensor
diagnosi
diseas
wang
et
al
zhu
et
al
graphen
oxid
nanosheet
gon
use
detect
vivo
cellular
interact
dna
cargo
function
shen
et
al
interact
fluorescencelabel
gon
dna
molecul
produc
aptamergon
complex
use
realtim
biosens
platform
live
cell
fluorescencelabel
atpbind
aptam
famaptam
potenti
use
biosens
system
gon
owe
three
basic
action
ie
high
fluoresc
quench
effici
vivo
potent
dna
transport
action
effici
protect
oligonucleotid
enzymat
cleavag
hong
et
al
sanchez
et
al
addit
famaptamergon
complex
high
atp
specif
sensit
wide
detect
rang
ie
mm
mm
vitro
wu
et
al
therefor
nanoparticl
also
expect
serv
molecular
tool
diagnosi
genet
diseas
quantum
dot
inorgan
fluoresc
semiconductor
nanoparticl
compos
atom
diamet
breger
et
al
mainli
use
biolog
imag
sens
detect
medicin
use
target
drug
deliveri
treatment
cancer
wang
et
al
apart
drug
deliveri
process
quantum
dot
also
use
deliveri
biomolecul
small
interf
rna
sirna
probst
et
al
hong
nam
limit
due
longterm
vivo
toxic
degrad
properti
liu
et
al
sobrova
et
al
dendrim
wellstructur
globular
macromolecul
three
region
core
layer
branch
repeat
unit
function
end
group
outer
layer
repeat
unit
bumb
et
al
highli
branch
natur
dendrim
provid
larg
surfac
area
allow
react
microorgan
vivo
shao
et
al
dendrim
drug
molecul
prepar
either
complex
encapsul
allow
load
hydrophob
hydrophil
agent
hydrophob
drug
load
insid
caviti
hydrophob
core
wherea
hydrophil
drug
attach
multival
surfac
dendrim
coval
conjug
electrostat
interact
formul
use
oral
transderm
ocular
intraven
rout
drug
deliveri
madaan
et
al
yavuz
et
al
addit
dendrim
shown
cross
cell
barrier
paracellular
transcellular
pathway
jone
et
al
polyamidoamin
dendrim
wide
use
drug
deliveri
potenti
action
facilit
transport
epitheli
barrier
xu
et
al
tyssen
et
al
howev
polyamidoamin
dendrim
affect
function
platelet
jone
et
al
structureeact
relationship
dendrim
reveal
dual
action
human
immunodefici
viru
hiv
herp
simplex
viru
hsv
ie
virucid
action
hsv
viral
entri
inhibitori
action
hiv
tyssen
et
al
addit
carri
sirna
deliv
specif
target
site
silenc
gene
sequenc
great
potenti
drug
deliv
capac
cn
xu
et
al
therefor
dendrim
particl
use
deliveri
sirna
gene
therapi
well
nanomedicin
neuroinfecti
disord
summari
variou
nanoparticl
applic
tabul
tabl
entri
nanoparticl
along
ligand
cellular
system
great
challeng
due
multipl
factor
size
biocompat
stabil
affin
mu
et
al
kettig
et
al
entri
nanoparticl
cellular
system
follow
principl
uptak
nanoparticl
tissu
cellular
receptoremedi
endocytosi
yameen
et
al
major
achiev
treatment
process
therapeut
agent
entri
uptak
drug
target
tissu
membran
layer
creat
obstacl
entri
drug
due
ineffici
partit
capac
kettig
et
al
partit
capac
depend
upon
polar
nonpolar
properti
drug
lipophil
molecul
bypass
obstacl
potent
membran
perm
via
diffus
mu
et
al
nanoparticl
abl
mask
therapeut
agent
provid
effici
deliveri
cytosol
region
nanoparticl
involv
endocytosi
process
natur
phagocytosi
pinocytosi
receptormedi
endocytosi
oh
park
phagocytosi
involv
ingest
materi
mm
diamet
cell
reticuloendotheli
system
eg
macrophag
neutrophil
dendrit
cell
uptak
mechan
almost
cell
type
normal
involv
submicromet
rang
materi
substanc
solut
kruth
larger
microparticl
enter
cytosol
action
phagocyt
cell
wherea
nanoparticl
cross
type
cell
receptormedi
endocytosi
potenti
select
entri
molecul
cellular
target
site
nanoparticl
surfac
bind
extracellular
surfac
cell
allow
carri
ligand
cytosol
region
wang
et
al
sometim
transduc
signal
intracellular
space
trigger
variou
biochem
pathway
furthermor
may
also
enhanc
intern
ligand
nanoparticl
via
endocytosi
process
process
potenti
biomolecul
caveolin
clathrin
rattanapinyopituk
et
al
smith
et
al
crosslink
receptor
nanoparticl
prone
membran
enfold
reunif
lead
format
endosom
nanoparticl
nm
size
involv
kind
entri
cellular
system
elsay
harashima
stekete
et
al
cellular
endocytosi
follow
five
step
carri
nanoparticl
ligand
cytosol
region
step
follow
associ
nanoparticl
receptor
cell
membran
intern
nanoparticl
ligand
releas
ligand
also
known
endosom
escap
nanoparticl
endolysosom
process
lysosom
degrad
nanoparticl
interact
free
ligand
therapeut
agent
cytoplasm
organel
protein
exocytosi
nanoparticl
via
endosom
recycl
process
xu
et
al
herd
et
al
serda
et
al
strobel
et
al
summari
nanoparticl
entri
elimin
cellular
system
illustr
fig
nanoparticl
success
develop
field
materi
scienc
inform
technolog
chemic
tissu
engin
scienc
addit
nanostructur
particl
potent
action
microbi
organ
great
potenti
action
drug
deliveri
process
weingart
et
al
investig
nanoparticl
medic
applic
stage
preclin
clinic
trial
nanoparticl
shown
produc
potenti
action
drug
deliveri
diagnosi
diseas
molecular
imag
cellular
function
drug
develop
gome
et
al
addit
nanomedicin
also
shown
therapeut
action
regen
medicin
stem
cell
gene
therapi
brain
tumor
cancer
implant
bone
repair
drug
discoveri
cosmet
applic
nitta
numata
jain
auffing
et
al
cheng
et
al
baetk
et
al
tautzenberg
et
al
nanoparticl
antimicrobi
agent
reach
market
treatment
variou
microbi
infect
gao
et
al
ku
et
al
postmarket
surveil
still
way
nanostructur
medicin
great
scope
treatment
lifethreaten
diseas
cancer
acquir
immun
defici
syndrom
neuroinfecti
diseas
masserini
viral
infect
import
factor
neuroinfectionassoci
neurodegener
exampl
human
tcell
lymphotrop
viru
epsteinebarr
viru
enceph
virus
hsv
parainfluenza
viru
infect
gaikwad
et
al
ahm
et
al
bili
et
al
viral
infect
caus
neurodegener
central
well
peripher
nervou
system
zhou
et
al
koyuncu
et
al
addit
theiler
murin
encephalomyel
viru
known
caus
neurodegen
diseas
ie
multipl
sclerosi
ms
sato
et
al
chronic
stage
viral
infectionassoci
neuron
damag
respons
produc
neurodegen
disord
like
hivassoci
dementia
alzheim
diseas
ad
parkinson
diseas
pd
ms
amyotroph
later
sclerosi
al
figur
process
nanomedicin
entri
elimin
nanoparticl
cellular
system
five
major
step
ie
associ
nanoparticl
cellular
membran
intern
endosom
complex
endolysosom
lysosom
degrad
releas
drug
activ
target
site
releas
nanoparticl
cellular
system
exocytosi
endosom
zhou
et
al
nanoparticl
report
prevent
viral
infect
nervou
system
bolhassani
et
al
therefor
nanomedicin
expect
cure
neuroinfectionassist
neurodegen
disord
howev
clinic
evid
nanomedicin
therapi
limit
novel
medic
applic
nanoparticl
nanomedicin
exhaust
need
investig
scientif
manner
treatment
lifethreaten
diseas
like
neuroinfecti
diseas
suitabl
molecular
mechan
therapeut
efficaci
well
avoid
toxic
principl
nanotechnolog
provid
improv
imag
system
human
bodi
fluoresc
microscopi
mri
scan
inorgan
nanoparticl
eg
quantum
dot
qd
possess
luminesc
properti
employ
novel
tool
diagnosi
biolog
function
diseas
progress
addit
strong
fluoresc
properti
ultraviolet
light
illumin
major
applic
qd
imag
tissu
cell
eg
lymph
node
tumor
hell
et
al
howev
type
nanoparticl
possess
superparamagnet
iron
oxid
potenti
therefor
recogn
detect
cancer
cell
progress
prostat
cancer
sterenczak
et
al
furthermor
gold
silver
nanoparticl
commonli
use
diagnosi
variou
cancer
cell
type
skin
ovarian
pancreat
breast
lung
cancer
austin
et
al
patra
et
al
swanner
et
al
deliveri
drug
nanoparticl
varieti
materi
protein
polysaccharid
synthet
polym
use
select
materi
nanoparticl
prepar
depend
upon
size
nanoparticl
inher
properti
drug
permeabl
degre
biodegrad
lohcharoenk
et
al
bolhassani
et
al
sizov
et
al
nanoparticl
abil
carri
drug
variou
type
cell
cancer
tumor
human
cell
nanoparticlemedi
deliveri
drug
observ
cancer
cell
line
cui
et
al
albuminload
nanoparticl
use
deliveri
paclitaxel
cancer
cell
reduc
advers
side
effect
associ
chemotherapeut
agent
abraxan
zhang
et
al
addit
nanoparticl
help
deliv
hiv
antivir
agent
hivinfect
organ
overcom
challeng
bioavail
hiv
antivir
agent
due
poor
watersolubl
parboos
et
al
us
food
drug
administr
fda
approv
nanomedicin
variou
patholog
disord
human
cancer
tumor
infect
kamali
et
al
etheridg
et
al
clinic
import
nanomedicin
therapeut
applic
list
tabl
deliveri
drug
cn
challeng
arrang
bloodebrain
barrier
bbb
gener
physiolog
barrier
limit
brain
uptak
neurotherapeut
agent
neuroimag
contrast
agent
ashton
et
al
anatom
cellular
manifest
cn
neurovascular
capillari
endotheli
cell
pinocytosi
tight
junction
limit
drug
deliveri
brain
microvasculatur
four
type
cell
ie
endotheli
cell
pericyt
astrocyt
foot
process
nerv
end
contribut
modul
drug
deliveri
cn
prevent
drug
entri
brain
shilo
et
al
gome
et
al
case
lipidmedi
free
diffus
receptormedi
endocytosi
great
role
entri
molecul
cn
therefor
lipidderiv
nanoparticl
like
liposom
contribut
great
success
drug
deliveri
neurolog
system
fonsecasanto
et
al
fiandaca
et
al
current
investig
focus
deliveri
nanostructur
medicin
treatment
neurolog
neuroinfecti
diseas
glioblastoma
dementia
ad
pd
al
fonsecasanto
et
al
ramoscabr
campo
current
concept
drug
deliveri
cn
focus
lowdens
lipoprotein
ldl
particl
size
natur
ldl
particl
nm
diamet
core
lipid
eg
cholesteryl
ester
small
amount
triglycerid
feng
mumper
mcmahon
et
al
plasmaderiv
ldl
use
deliv
nanomedicin
neurolog
tumor
glioblastoma
synthet
ldl
nanoparticl
also
provid
effici
deliveri
paclitaxel
glioblastoma
feng
mumper
vascular
diseas
contribut
progress
neurolog
ischemia
lead
stroke
cerebr
aneurysm
intracrani
hemorrhag
sehba
et
al
chen
et
al
deliveri
nanoparticl
cn
help
detect
neurovascular
diseas
detect
atherosclerot
plaqu
similarli
also
act
target
deliv
therapeut
agent
plaqu
tissu
factortarget
nanoparticl
load
paclitaxel
shown
reduc
smooth
muscl
cell
prolifer
chan
et
al
addit
nanoparticl
load
fumagillin
antiangiogen
agent
target
epitop
vasa
vasorum
document
produc
antiangiogen
effect
lanza
et
al
util
taxolload
albumin
nanoparticl
limit
restenot
respons
experiment
anim
chan
et
al
degener
neurolog
system
trigger
infect
inflamm
oxid
stress
subsequ
modul
variou
cellular
molecular
event
nervou
system
mishra
et
al
alirezaei
et
al
nanoparticl
great
potenti
regul
microb
antimicrobi
agent
et
al
nanoparticl
abl
cross
cn
alter
neurolog
protein
upadhyay
base
evid
expect
control
variou
neurolog
diseas
convent
medicin
limit
treat
neurodegen
diseas
difficulti
drug
deliveri
toxic
profil
neurolog
well
system
organ
carrol
et
al
chhabra
et
al
perreault
et
al
singh
ramarao
therefor
nanoparticl
nanomedicin
promis
technolog
treatment
neurodegen
disord
howev
experiment
clinic
evid
explor
role
nanomedicin
treatment
neurodegen
diseas
limit
contrast
possibl
benefit
variou
nanoparticl
metal
natur
metal
compound
well
document
produc
neurolog
damag
willhit
et
al
chelat
report
reduc
metal
compound
associ
neuron
damag
zhang
et
al
zhao
et
al
hand
metal
chelat
eg
desferrioxamin
exhibit
seriou
neurotox
neurolog
chang
due
strong
coval
bind
properti
membran
protein
olivieri
et
al
kapoor
ldlreceptortarget
polymer
nanoparticl
potenti
cross
bbb
taken
brain
endotheli
cell
deliv
drug
brain
effect
mask
coval
bond
chelat
facilit
deliveri
drug
minim
toxic
kreuter
therefor
nanoparticl
play
signific
role
manag
neurodegen
diseas
scienc
nanotechnolog
expect
treat
neuroinfect
neurodegen
cerebrovascular
inflammatori
diseas
major
challeng
drug
deliveri
brain
low
permeabl
bbb
role
natur
brainprotect
layer
entri
foreign
substanc
blood
microb
monopoli
et
al
usag
polymer
nanoparticl
demonstr
potenti
noninvas
drug
carrier
cross
bbb
enter
brain
ong
et
al
patel
et
al
antitubercular
drugload
nanoparticl
capac
enter
mycobacterium
tuberculosi
organ
produc
potent
efficaci
tuberculosi
tb
garg
et
al
pandey
et
al
oral
administr
five
oral
dose
everi
day
coencapsul
poli
dllactidecoglycolid
nanoparticl
antitubercular
drug
eg
rifampin
isoniazid
pyrazinamid
produc
complet
bacteri
clearanc
organ
compar
convent
tb
drug
mice
guinea
pig
pandey
et
al
sharma
et
al
moreov
oral
administr
poli
dllactidecoglycolid
nanoparticl
encapsul
ethionamid
produc
potent
tissu
distribut
manag
multidrugresist
tb
sustain
releas
ethionamid
day
plasma
compar
plasma
concentr
free
ethionamid
mice
shown
kumar
et
al
therefor
nanoparticl
potenc
deliv
drug
infect
organ
level
nervou
system
nervou
system
variou
selfdefens
cell
like
glial
cell
astrocyt
oligodendrocyt
macrophag
b
cell
alluri
et
al
tsunoda
gener
play
role
central
sensit
protect
cn
wherea
overactiv
cell
respons
chang
neurolog
function
extrem
stage
caus
neurodegener
jungner
et
al
abnorm
activ
cell
due
variou
intern
extern
factor
stress
drug
chemic
trauma
surgeri
heat
hormon
microb
peripher
nerv
injuri
alizadeh
et
al
goncharenko
et
al
lee
et
al
et
al
villanueva
et
al
mechan
neurodegener
take
place
via
releas
variou
proinflammatori
cytokin
tumor
necrosi
factor
leukotrien
excitatori
neurotransmitt
glutam
aspart
oxid
stress
neuron
camaralemarroy
et
al
wang
et
al
ramesh
et
al
endothelium
cn
primari
target
site
neuroinfect
neuroinflamm
di
marco
et
al
chang
central
endothelium
affect
neurolog
function
via
activ
neuron
glial
cell
chronic
stage
undergo
enhanc
neurodegener
loan
et
al
infecti
agent
caus
neuroinflamm
affect
endothelium
cerebr
blood
vessel
astrocyt
comb
et
al
freeman
et
al
mening
neuroinflammatori
condit
cn
caus
bacteri
streptococcu
pneumonia
n
meningitidi
haemophilu
influenza
listeria
monocytogen
escherichia
coli
tuberculosi
viral
varicella
zoster
influenza
mump
hiv
hsv
fungal
cryptococcu
neoforman
parasit
cysticercosi
infect
inou
et
al
richi
josephson
enceph
anoth
neuroinflammatori
condit
cn
caus
enterovirus
herp
simplex
rabi
viru
arbovirus
nile
viru
viru
particl
prone
caus
neuroinflamm
neurodegener
kurkowskajastrzebska
et
al
richi
josephson
gener
virus
abl
infiltr
nervou
system
entri
viru
particl
nervou
system
involv
two
method
ie
transneuron
hematogen
spread
method
chave
et
al
coller
smith
taylor
enquist
exact
mechan
transneuron
spread
virus
known
yet
expect
involv
viru
protein
escap
immun
system
travel
via
axon
nerv
feldman
et
al
rall
et
al
turner
et
al
hematogen
spread
method
viru
use
one
two
main
way
enter
brain
first
way
infect
immun
cell
thereaft
infect
immun
cell
carri
viru
nervou
tissu
exampl
infect
b
cell
john
cunningham
viru
type
human
polyomaviru
infect
cell
macrophag
hiv
chapagain
nerurkar
teba
et
al
second
way
cross
blood
capillari
similar
free
viru
leukocyt
entri
roe
et
al
furthermor
neuron
lack
essenti
molecul
bind
killer
cell
viral
peptid
viral
surfac
therefor
neuron
safe
hous
viru
replic
deauvieau
et
al
voss
bryceson
viru
infect
neuron
persist
lifetim
host
interfer
function
neuron
homeostasi
nervou
system
lead
gener
neuron
damag
neurodegener
de
chiara
et
al
infect
agent
affect
neurolog
system
caus
neurodegen
diseas
ad
pd
al
alkhawajah
et
al
bourgad
et
al
devaughn
et
al
wu
et
al
progress
infect
neurodegener
occur
wide
rang
molecular
cellular
mechan
lead
deterior
loss
neuron
cn
infecti
neurodegener
occur
cn
also
affect
peripher
nervou
system
enhanc
neuron
inflamm
neurodegener
ramesh
et
al
wada
et
al
lead
peripher
neuropathi
peripher
neuropathi
mainli
develop
infect
herp
varicella
zoster
call
shingl
hsv
cytomegalovirus
guedon
et
al
muneshig
et
al
sanson
sanson
epsteinebarr
viru
west
nile
viru
play
role
develop
peripher
neuropathi
viral
infect
abl
affect
nervou
system
caus
sever
damag
sensori
motor
nerv
lead
sharp
sever
pain
chikakiyo
et
al
jo
et
al
kokoti
et
al
moreov
infect
west
nile
viru
occur
mosquito
caus
sever
motor
neuropathi
along
variou
form
inflammatori
neuropathi
infect
postherpet
neuralgia
also
shown
produc
longlast
intens
pain
attack
shingl
sanson
sanson
hiv
infectionassoci
neuropathi
show
differ
form
depend
nerv
affect
specif
stage
activ
hiv
diseas
kokoti
et
al
furthermor
bacteria
attack
nervou
tissu
caus
peripher
nerv
damag
neuropath
pain
bacteri
infect
diphtheria
leprosi
lyme
diseas
benoliel
et
al
rei
et
al
zimer
et
al
addit
tickborn
infect
also
contribut
neuroinfectionassoci
neuropath
pain
rapidli
develop
infect
progress
pain
polyneuropathi
occur
within
week
infect
logigian
steer
zimer
et
al
therefor
prevent
neuron
infect
may
promis
approach
treatment
neurodegen
disord
nanoparticl
nanomedicin
contribut
variou
pharmaceut
applic
like
diagnosi
diseas
progress
drug
deliveri
treatment
variou
ailment
cancer
thrombosi
wound
osteoporosi
vertebr
fractur
microbi
infect
diseas
eg
tb
hivassoci
opportunist
infect
khajuria
et
al
palekar
et
al
sagar
et
al
tang
et
al
wolfram
et
al
furthermor
expect
produc
potenti
therapeut
agent
neuroinfect
disord
possibl
cellular
molecular
mechan
follow
nervou
system
nanomedicin
cross
bbb
directli
regul
physiolog
respons
bbb
brain
function
carri
circul
immunocyt
monocyt
macrophag
lymphocyt
stem
cell
brain
nowacek
gendelman
releas
cargo
materi
control
ongo
diseas
progress
clear
microbi
infect
repair
neuron
system
elimin
proinflammatori
mediat
induc
antiinflammatori
respons
raymond
et
al
combin
action
nanomedicin
neuron
function
may
restor
glial
homeostasi
function
brain
cellular
mechan
nanomedicin
treatment
infecti
neurodegen
diseas
illustr
fig
nanostructur
antimicrobi
drug
target
mainli
receptor
brain
endotheli
cell
insulin
leptin
transferrin
epiderm
growth
factor
receptor
transfer
lead
molecul
across
bbb
gendelman
et
al
hu
kesari
addit
also
target
receptor
monocytesmacrophag
folat
mannos
receptor
enhanc
cellular
uptak
nanomedicin
macrophagebas
drug
deliveri
brain
via
bbb
irvin
et
al
nanomedicin
follow
six
step
elimin
microb
nervou
system
biolog
system
hollmann
et
al
entri
nanomedicin
nervou
system
attract
bind
microb
thereaft
carri
follow
step
destroy
peptidoglycan
membran
layer
microb
lead
control
microbi
growth
releas
toxic
metal
ion
cytosol
region
microb
caus
microbi
death
alter
cellular
ionic
environ
activ
proton
efflux
pump
lead
chang
ph
enhanc
gener
free
radic
especi
reactiv
oxygen
speci
ro
lead
rais
oxid
stress
damag
genet
materi
microbi
organ
thu
stop
regul
microbi
growth
replic
reduc
atp
product
thu
increas
energi
demand
control
microbi
growth
prolifer
rizzello
et
al
upadya
et
al
watkin
et
al
shah
et
al
molecular
mechan
nanomedicin
elimin
microb
nervou
system
illustr
fig
therefor
nanomedicin
achiev
therapeut
action
neuroinfectionassoci
neurodegen
diseas
base
discuss
approach
use
nanostructur
antimicrobi
agent
nanomedicin
use
treatment
neuroinfecti
neurodegen
diseas
imag
drug
deliveri
function
nanoparticl
success
explor
pharmaceut
scienc
even
produc
potent
therapeut
ratio
index
margin
level
nanoparticl
act
drug
carrier
figur
cellular
mechan
nanomedicin
treatment
infecti
neurodegen
diseas
microbi
infect
potenti
alter
function
neuron
glial
cell
enhanc
inflammatori
reaction
via
proinflammatori
mediat
nanomedicin
cross
bloodebrain
barrier
bbb
help
monocyt
macrophag
lymphocyt
stem
cell
furthermor
induc
microbi
death
regul
glial
function
repair
neuron
damag
lead
prevent
infectionassoci
neurodegener
reduc
toxic
drug
howev
toxic
effect
whole
formul
nanoparticl
drug
nanoparticl
describ
yet
therefor
potenti
usag
nanostructur
nanoparticl
nanomedicin
remain
question
potenti
toxic
clinic
efficaci
advers
side
effect
baezasquiban
krishnaraj
et
al
walter
et
al
scientif
studi
need
explor
complet
safeti
efficaci
human
studi
bioavail
biotransform
environment
toxic
etc
need
battani
et
al
walter
et
al
true
applic
nanoparticl
treatment
diseas
requir
improv
specif
formul
safeti
efficaci
minim
cellular
toxic
opinion
toxicologist
new
scienc
method
protocol
need
higher
safeti
profil
util
nanoparticl
nanomedicin
hofmannamtenbrink
et
al
base
discuss
follow
point
must
consid
develop
nanostructur
nanomateri
nanomedicin
proper
test
nanoparticl
nanomedicin
devic
advanc
techniqu
studi
pharmacokinet
especi
distribut
biotransform
pharmacodynam
properti
nanoparticl
biolog
system
studi
effect
nanoparticl
exposur
biolog
environment
level
respect
degrad
toxic
hofmannamtenbrink
et
al
schutz
et
al
lin
et
al
toxic
exposur
overcom
follow
way
method
risk
assess
nanomedicin
nanodevic
must
appropri
assay
perform
detect
potenti
risk
method
assay
techniqu
need
depend
upon
type
nanoparticl
use
whether
biolog
nonbiolog
origin
write
studi
nanoparticl
lack
basic
understand
nanoparticl
pharmacokinet
behavior
biolog
system
especi
distribut
biotransform
nanoparticl
organ
cellular
level
nanoparticl
small
size
particl
may
chang
bodili
function
pass
bbb
trigger
abnorm
blood
coagul
pathway
nanoparticl
must
degrad
without
develop
harm
effect
anim
plant
environment
natur
resourc
therefor
presenc
nanoparticl
must
detect
biolog
environment
system
stage
major
import
detect
slowli
nondegrad
nanoparticl
nanotoxicolog
newer
branch
scienc
deal
studi
applic
nanomateri
regard
toxic
human
environ
mainli
nanotoxicolog
studi
intend
determin
extent
toxic
properti
threaten
environ
human
be
guadagnini
et
al
type
toxic
exposur
nanoparticl
follow
consum
exposuredusag
nanoparticlecontain
person
care
product
cosmet
figur
molecular
mechan
nanomedicin
elimin
microb
nervou
system
six
major
step
destruct
peptidoglycan
layer
releas
toxic
metal
ion
alter
proton
efflux
pump
gener
free
radic
damag
genet
materi
reduct
atp
product
sunscreen
prepar
occup
exposuredfor
worker
nanomateri
manufactur
research
environment
exposuredth
increas
concentr
nanomateri
groundwat
soil
may
produc
signific
environment
risk
malysheva
et
al
moreov
toxic
nanomateri
broadli
classifi
two
area
biolog
toxic
environment
toxic
biolog
system
nanostructur
nanoparticl
enter
bodi
via
six
principl
rout
ie
oral
intraven
dermal
subcutan
inhal
intraperiton
particl
enter
system
circul
distribut
variou
organ
bodi
may
remain
structur
modifi
metabol
cellular
system
caus
biolog
toxic
dna
damag
ro
gener
lead
tissu
damag
inflamm
cytotox
organ
failur
deposit
nanoparticl
also
caus
fibrosi
allergi
fu
et
al
malysheva
et
al
environment
system
nondegrad
nanoparticl
readi
deposit
groundwat
lead
product
environment
pollut
may
also
harm
plant
microb
remov
nanoparticl
environ
anoth
challeng
task
manag
nanotox
pourgashtasbi
nanoparticl
alreadi
exist
natur
eg
volcan
ash
ocean
spray
forest
fire
smoke
highli
toxic
exist
chemic
nanoparticl
eg
carbon
nanotub
also
abl
produc
toxic
effect
pourgashtasbi
argu
natur
nanoparticl
consider
new
phenomenon
come
daili
human
activ
like
mine
cook
combust
materi
gao
et
al
nanoparticl
studi
shown
special
properti
ie
ultrasmalls
particl
extrem
mobil
higher
propag
live
organ
control
creat
toxic
effect
per
unit
compar
larger
particl
chemic
absorb
quickli
cell
move
quickli
contamin
environ
air
soil
water
lead
damag
plant
anim
baalousha
lead
kind
nanoparticl
respons
caus
inflammatori
reaction
lung
carbon
black
nanoparticl
qd
polymer
nanoparticl
consid
uniform
group
nanoparticl
interact
behav
differ
manner
depend
upon
sever
factor
podila
brown
lack
data
potenti
risk
nanoparticl
nanomedicin
respect
human
bodi
environ
rais
question
issu
scientif
research
must
answer
mani
question
allow
util
nanoparticl
human
be
environment
friendli
approach
question
follow
nanoparticl
pathway
affect
human
bodi
long
nanoparticl
remain
human
bodi
nanoparticl
effect
cellular
tissu
function
cochran
et
al
main
challeng
nanoparticl
usag
identif
toxicityfre
nanoparticl
legal
evalu
final
medic
product
elimin
particl
biolog
environment
system
nanomedicin
remain
challeng
fall
tradit
classif
drug
medic
devic
furthermor
risk
analys
nanoparticl
complic
lack
data
techniqu
issu
ilinskaya
dobrovolskaia
b
outcom
use
nanomedicin
treatment
must
satisfi
regulatori
environment
social
ethic
issu
us
fda
effect
regul
use
nanoparticl
strong
technolog
scientif
advanc
gener
fda
classifi
regulatori
process
medic
product
drug
devic
biolog
combin
product
lack
regul
nanomedicin
aspect
lack
scientif
expertis
classif
difficulti
bowman
gatof
leit
et
al
environment
aspect
excretori
materi
mainli
suspend
air
long
period
caus
respiratori
disord
nation
scienc
foundat
environment
protect
agenc
rais
issu
potenti
impact
nanomateri
environ
advers
effect
social
issu
usag
neurobiochip
stimul
brain
human
manipul
neuropsycholog
factor
social
ethic
issu
debat
regard
implant
nanodevic
close
monitor
ill
privaci
right
risk
abus
price
nanodevic
would
high
anoth
social
issu
one
affect
develop
nation
leit
et
al
ethic
issu
concern
prove
nanoparticl
nontox
ecofriendli
unabl
use
terror
purpos
easi
remov
toxic
effect
produc
bodi
king
resnik
sechi
et
al
major
concern
nanoparticl
applic
nanostructur
toxic
depend
upon
physic
characterist
individu
new
particl
ongo
research
report
give
answer
solv
biolog
environment
toxic
stage
nanostructur
nanoparticl
nanomedicin
provid
high
sensit
specif
low
cost
portabl
reusabl
nanoparticl
great
invent
field
pharmaceut
medic
scienc
variou
technolog
establish
detect
fine
particl
scientif
uncertainti
surround
outcom
nanomedicin
bello
et
al
ji
et
al
best
case
scenario
bring
success
nanoparticl
usag
pharmaceut
field
provid
fundament
basi
intensifi
research
scienc
disciplin
one
side
data
need
scientif
evid
toxicolog
profil
nanoparticl
side
develop
nanoparticl
process
scientif
task
also
requir
answer
issu
question
jurist
legal
scholar
report
scientif
discoveri
follow
standard
guidelin
provid
minimum
safeti
standard
accept
protect
human
health
point
view
nanotechnolog
offer
opportun
major
integr
among
differ
disciplin
especi
scienc
law
therefor
nanostructur
antimicrobi
agent
futur
nanomedicin
neuroinfectionassist
neurodegen
disord
variou
nanomateri
report
drug
deliveri
process
therapeut
level
biolog
system
great
potenti
enter
microb
releas
drug
thu
drug
deliveri
nanostructur
system
antimicrobi
action
wide
explor
preclin
well
clinic
research
import
advantag
nanomedicin
low
side
effect
deliveri
accur
dose
siteand
targetspecif
region
nanomedicin
offer
possibl
prevent
diagnos
treat
diseas
open
promis
area
field
medicin
therefor
nanostructur
medicin
futur
goal
treatment
neuroinfectionassoci
neurodegen
disord
like
hivassoci
dementia
ad
pd
al
ms
includ
neuropath
pain
